Beta Bionics BBNX
NASDAQ BBNX
$18.96 +0.09 (+0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Beta Bionics (BBNX) Gains from Sales and Divestitures (2024)

Updated

Beta Bionics (BBNX) posted Gains from Sales and Divestitures of -$31,000 for FY2025, compared with -$23,000 in FY2024.

Analysis

Beta Bionics (BBNX) Gains from Sales and Divestitures (2024) Analysis & Trends

  • Business Quant data shows BBNX's Gains from Sales and Divestitures at -$23,000 in FY2024 and -$11,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Beta Bionics 852.85 Mn 25.03 Mn 18.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -15,000.00
Mar 31, 2024 -8,000.00
API Access

Beta Bionics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BBNX&period=max&api_key=YOUR_API_KEY